Current Edition

Regional News

Floating material found in Pfizer COVID-19 vaccine vials in Japan, but company says it’s not contamination

In recent weeks, Moderna has had to deal with reports of contaminants discovered in vials of its COVID-19 vaccine in Japan. Now it’s Pfizer doing the same after whit...
Continue Reading →
Regional News

Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028

As a top-selling drug worldwide, Pfizer and Bristol Myers Squibb’s Eliquis is a major target for generic players looking to steal branded sales. But with a new court ...
Continue Reading →
Regional News

FDA approval of Pfizer’s COVID-19 vaccine spurs American confidence: Harris Poll

Last week's FDA approval of Pfizer’s Comirnaty vaccine boosted consumer confidence among both vaccinated and unvaccinated people. A Harris Poll survey over the weeke...
Continue Reading →
Regional News

Pfizer’s tick-borne encephalitis vaccine TicoVac passes FDA muster, allowing travelers and the military easier access

Pfizer's vaccines group has been on a roll, generating world-leading COVID-19 shot sales and scoring a June approval for a much-anticipated Prevnar 13 follow up. Late...
Continue Reading →
Regional News

Viatris shows no signs of growing pains in its ‘trough year,’ but one analyst has longer-term worries

Viatris CEO Michael Goettler may well consider this a “trough” year for his newly formed company. But only months after he made that declaration, Viatris reported fig...
Continue Reading →
Regional News

BioNTech, eyeing $18B-plus in COVID-19 vaccine sales this year, poised to join the ranks of the world’s top drugmakers

The COVID-19 pandemic helped put mRNA vaccines on the map. Now, thanks to the shots' quick uptake in rich countries, mRNA specialist BioNTech appears poised to join t...
Continue Reading →
Regional News

Pfizer now expects COVID vaccine sales to reach $33.5B this year, a whopping $7.5B bump from its estimate 3 months ago

We’re seeing victory laps these days during the Summer Olympic Games. Now it’s Pfizer’s turn. Three months after estimating 2021 revenues for its COVID-19 vaccine Co...
Continue Reading →
Regional News

Pharma giants, led by Pfizer and J&J, play COVID card to fight global tax deal: WSJ

Pharma is already playing the COVID card. In the face of a comprehensive global tax agreement intended to stymie opportunities for tax avoidance, industry executives...
Continue Reading →